These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7380764)

  • 21. [Prevention of hospital infection: the compromised host and drug-resistant bacteria].
    Shimizu K
    Kango Tenbo; 1987 Sep; 12(10):980-2. PubMed ID: 3682913
    [No Abstract]   [Full Text] [Related]  

  • 22. [The in vitro activity of 4 aminosides on gram-negative bacteria].
    Ben Chaabane T; Ben Redjeb S; Bouzouia N; Kechrid A; Ben Salem N; Zribi A; Boujnah A
    Tunis Med; 1984 Dec; 62(8):591-4. PubMed ID: 6531815
    [No Abstract]   [Full Text] [Related]  

  • 23. [Characteristics of the composition of the causative agents of different forms of suppurative inflammatory diseases and their antibiotic sensitivity].
    Levina EN; Kuznetsova SM; Samoĭlova LN; Speranskaia ON; Sinitsina GG
    Antibiot Med Biotekhnol; 1985 Sep; 30(9):681-4. PubMed ID: 3933419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Resistance of gram-negative bacilli to 6 aminoglycosides].
    Broussain MT; Pinto ME; Cona E
    Rev Med Chil; 1985 Dec; 113(12):1210-6. PubMed ID: 3016857
    [No Abstract]   [Full Text] [Related]  

  • 25. A laboratory assessment of the activities of four aminoglycosides.
    Schrire L; Robinson RG; Koornhof HJ
    S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of extrachromosomal drug resistance. The role of drug-resistant and drug-selected bacteria in nosocomial disease.
    Isenberg HD; Berkman JI
    Ann N Y Acad Sci; 1971 Jun; 182():52-8. PubMed ID: 5285296
    [No Abstract]   [Full Text] [Related]  

  • 27. Aminoglycosides versus bacteria--a description of the action, resistance mechanism, and nosocomial battleground.
    Shakil S; Khan R; Zarrilli R; Khan AU
    J Biomed Sci; 2008 Jan; 15(1):5-14. PubMed ID: 17657587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of cefoxitin, alone and in combination with aminoglycoside or other beta-lactam antibiotics against common gram-negative pathogens.
    Markowitz SM; Sibilla DJ
    Chemotherapy; 1983; 29(2):89-98. PubMed ID: 6839865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trends in bacterial susceptibility to antimicrobial agents.
    Lane MM; Parker DE; Flournoy DJ
    Chemotherapy; 1985; 31(6):433-9. PubMed ID: 3935395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis.
    Daneman N; Sarwar S; Fowler RA; Cuthbertson BH;
    Lancet Infect Dis; 2013 Apr; 13(4):328-41. PubMed ID: 23352693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New aminoglycosides effective with regard to resistant bacteria].
    Gauze GF
    Antibiotiki; 1980 Sep; 25(9):710-4. PubMed ID: 6998372
    [No Abstract]   [Full Text] [Related]  

  • 32. [Antibiotic sensitivity of microbial strains isolated from the hospital environment].
    Debeleac L; Voicescu V; Dumitrescu MR; Covacu A; Slavov N; Georgescu M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1987; 32(3):225-34. PubMed ID: 3438652
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative in vitro activity of BAY Y 3118 with other fluoroquinolones.
    Molinari G; Schito GC
    Drugs; 1995; 49 Suppl 2():222-5. PubMed ID: 8549310
    [No Abstract]   [Full Text] [Related]  

  • 34. Gram-negative bacilli isolated from patients in intensive care unit: prevalence and antibiotic susceptibility.
    Eltahawy AT
    J Chemother; 1997 Dec; 9(6):403-10. PubMed ID: 9491839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Minimal inhibitory concentration in hospital bacteria].
    Marcenac FM; Fernández AJ; Rebollo MN; Helou HT; Civalero TR; Herran IL; Magri MA
    Rev Asoc Argent Microbiol; 1974; 6(2):44-61. PubMed ID: 4467221
    [No Abstract]   [Full Text] [Related]  

  • 36. [Enterococci: acquired antibiotic resistance].
    Alonso T; Pérez JL; Liñares J
    Enferm Infecc Microbiol Clin; 1992 Oct; 10(8):489-96. PubMed ID: 1489779
    [No Abstract]   [Full Text] [Related]  

  • 37. [Consumption of aminoglycosides and incidence of resistant gram-negative bacteria in the regional hospital of Perugia].
    Bianchi P; Frongillo RF
    Clin Ter; 1985 Nov; 115(4):279-82. PubMed ID: 3936663
    [No Abstract]   [Full Text] [Related]  

  • 38. [Aminoglycoside resistance in gramnegative pathogens of nosocomial infections in Russia].
    Reshed'ko GK
    Antibiot Khimioter; 2004; 49(5):11-23. PubMed ID: 15573898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in microbial ecology by therapeutic use of aminoglycosides.
    Bauernfeind A; Hörl G; Mönch V
    Scand J Infect Dis Suppl; 1986; 49():106-14. PubMed ID: 3547617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antibiotic resistance at a hospital environment. Observations from 1980 to 1986].
    Pistono PG; Piro F; Guasco C; Malcangi A; Martinetto P
    G Batteriol Virol Immunol; 1987; 80(1-12):25-168. PubMed ID: 3509032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.